Zanamivir hydrate

• CAT Number: L016031
• CAS Number: 1260601-68-0
• Molecular Formula: C12H22N4O8
• Molecular Weight: 350.33
• Purity: ≥95%
• IUPAC Name: (2R,3R,4S)-3-acetamido-4-(diaminomethylideneamino)-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid;hydrate
• InChI: InChI=1S/C12H20N4O7.H2O/c1-4(18)15-8-5(16-12(13)14)2-7(11(21)22)23-10(8)9(20)6(19)3-17;/h2,5-6,8-10,17,19-20H,3H2,1H3,(H,15,18)(H,21,22)(H4,13,14,16);1H2/t5-,6+,8+,9+,10+;/m0./s1
• InChIKey: OELRRAURPSTFEX-VCFRRRQNSA-N
• SMILES: CC(=O)NC1C(C=C(OC1C(C(CO)O)O)C(=O)O)N=C(N)N.O

Zanamivir hydrate（Cat No.:L016031）is an antiviral medication used to treat and prevent influenza A and B infections. As a neuraminidase inhibitor, it blocks the influenza virus from releasing new viral particles, halting the spread of infection within the respiratory tract. Administered via inhalation, Zanamivir hydrate is most effective when given early in the course of infection, reducing symptom duration and severity. Its rapid action and targeted delivery make it a valuable option in flu management, especially for patients resistant to other antivirals, enhancing outcomes in seasonal and outbreak scenarios.